Body roundness index: the waist measurement that predicts metabolic risk better than BMI
Two women share the same height, the same weight, and the same BMI, and still carry completely different amounts of fat around their organs. BMI cannot tell them apart. It reads height and weight, nothing else, and it treats a pound of muscle in the thigh the same as a pound of fat wrapped around the liver.
The body roundness index reads something BMI ignores. It uses waist circumference alongside height to estimate visceral fat, the deep abdominal fat packed around the organs that drives insulin resistance and cardiovascular risk. In a 2026 study of perimenopausal and postmenopausal women published in Annals of Medicine, the body roundness index outranked every other marker the researchers tested as a predictor of metabolic syndrome, including several blood tests.
This article explains what the body roundness index measures, why fat relocates to your middle during the menopause transition, how to take the measurement correctly at home, and what your number means once you have it.
Table of contents
- What the body roundness index measures that BMI misses
- Why fat relocates to your middle during the menopause transition
- How to measure your waist correctly and find your number
- BRI compared with BMI, waist circumference, and body scans
- Where Botavive Berberine 1200 fits into a metabolic plan
- Frequently asked questions
Key takeaways
| The measure | What the evidence shows |
|---|---|
| Body roundness index | Built from waist circumference and height. Estimates visceral fat, which BMI cannot detect. |
| Ranking against other markers | In perimenopausal and postmenopausal women, BRI ranked as the strongest contributor to metabolic syndrome prediction, ahead of white blood cell count, ALT, MCV, and AST (Xi et al., 2026). |
| Risk distribution | A U-shaped curve. Across 32,995 US adults, all-cause mortality risk rose 25% below a BRI of 3.4 and 49% at 6.9 or above, compared with the middle range of 4.5 to 5.5 (Zhang et al., 2024). |
| Population trend | Average US body roundness index rose from 4.80 to 5.62 between 1999 and 2018. The climb was steeper among women than the population average. |
| The 30-second shortcut | NICE guidance advises keeping your waist under half your height. A waist-to-height ratio of 0.4 to 0.49 sits in the healthy range. |
| Menopause context | Menopause worsens nearly every component of metabolic syndrome. Surgical menopause carries 1.51 times the risk of natural menopause (Pu et al., 2017). |
What the body roundness index measures that BMI misses
BMI divides your weight by the square of your height. That is the whole calculation. It produces one number that describes how heavy you are relative to how tall you are, and it says nothing about composition or distribution. A lean, muscular woman and a woman carrying substantial abdominal fat land in the same category if their height and weight match.
Fat location matters more than fat quantity for metabolic risk. Subcutaneous fat sits under the skin, on the hips, thighs, and upper arms. It is metabolically quiet. Visceral fat sits deeper, wrapped around the liver, pancreas, and intestines. It behaves like an active endocrine organ, releasing inflammatory signals and free fatty acids directly into the portal circulation that feeds the liver. That is the fat that pushes fasting glucose up, drags HDL cholesterol down, and raises triglycerides.
The body roundness index was designed to estimate that deep fat without a scan. It models the body as an ellipse and uses the relationship between waist circumference and height to describe how round that ellipse is. A tall woman with a 32-inch waist and a short woman with a 32-inch waist do not carry the same proportional visceral load, and BRI accounts for that difference. Waist circumference alone does not.
The 2026 Annals of Medicine study put this to a direct test. Researchers at Dalian Medical University trained eight machine learning models on NHANES data from 2007 to 2020, then validated the best performer against a separate hospital cohort in China. They fed the models 16 predictors selected from an initial pool of 44 variables, including blood markers. The artificial neural network reached an area under the curve of 0.854 internally and 0.878 in external validation. When they ranked which inputs drove the predictions, body roundness index came out on top.
That result is worth sitting with. In a population of perimenopausal and postmenopausal women, a number derived from a tape measure and a height chart carried more predictive weight than liver enzymes and blood counts.
Why fat relocates to your middle during the menopause transition
Estrogen governs where the body stores fat. While estrogen levels are steady, storage favors the hips, thighs, and buttocks, the pattern sometimes described as gynoid. As estrogen falls through perimenopause and into postmenopause, that preference shifts toward the abdomen, and a larger share of new storage goes to the visceral compartment rather than under the skin.
This is why the scale sometimes stays flat while clothes stop fitting. Total weight holds steady, but the distribution reorganizes. A woman whose weight has not moved in three years might still see her waist grow by two or three inches across the transition, and her metabolic risk rises with it even though her BMI reports no change at all.
The 2017 Climacteric meta-analysis by Pu and colleagues examined this across the available literature. Comparing postmenopausal with premenopausal women, nearly every component of metabolic syndrome moved in the unfavorable direction. Waist circumference, fasting glucose, triglycerides, and blood pressure all worsened. HDL cholesterol was the single exception. The same analysis found that women who went through surgical menopause carried 1.51 times the metabolic syndrome risk of women who reached menopause naturally, which points to the abruptness of the hormonal drop as part of the mechanism.
Several forces stack on top of the hormonal shift:
- Reduced resting energy expenditure. Lean muscle mass declines with age, and muscle is the tissue that burns the most calories at rest.
- Rising insulin resistance. Visceral fat worsens insulin sensitivity, and worsening insulin sensitivity promotes more visceral storage. The loop reinforces itself.
- Cortisol patterns. Sleep disruption and stress during the transition raise cortisol, which preferentially directs fat toward the abdomen.
- Altered fat oxidation. The body burns a smaller proportion of fat for fuel after menopause onset.
How to measure your waist correctly and find your number
The measurement takes 30 seconds and most people get it wrong the first time. Accuracy matters here because a one-inch error moves your result meaningfully.
Take the measurement: Stand upright with a soft cloth tape. Wrap it around your bare midsection at the level of your belly button, or at the narrowest point of your natural waist if that is easier to locate consistently. Keep the tape horizontal all the way around and snug against the skin without compressing it. Breathe in, breathe out, and read the number at the end of the exhale. Do not hold your breath and do not pull your stomach in.
Measure your height without shoes, standing straight against a wall.
Run the shortcut first. Divide your waist by your height. Both numbers need to be in the same unit, so inches divided by inches, or centimeters divided by centimeters. NICE guidance in the UK sorts the result into three bands:
- 0.40 to 0.49, healthy central adiposity. No increased health risk from central fat.
- 0.50 to 0.59, increased central adiposity. Increased health risk.
- 0.60 or above, high central adiposity. Further increased health risk.
Worked example. A woman who is 5 foot 4 stands 64 inches tall. With a 38-inch waist, her ratio is 38 divided by 64, which comes to 0.59. That sits at the top of the increased central adiposity band. Half her height would be 32 inches, so she is six inches above the screening threshold.
For the body roundness index itself, use a calculator. The formula involves an eccentricity term and a square root, and it is not something to compute reliably by hand. There is a further reason to be careful: the original JAMA Network Open paper that popularized BRI thresholds was later issued a formal correction for an error in the printed formula. Use a reputable online calculator, enter waist and height in the units it asks for, and read the output.
Pro Tip: Measure at the same time of day, ideally first thing in the morning before eating, and record the number rather than trusting memory. Bloating, meal timing, and menstrual cycle position all move waist circumference by an inch or more, so a single reading tells you less than four readings taken across a month.
BRI compared with BMI, waist circumference, and body scans
No single measurement answers every question, and BRI is a screening tool rather than a diagnosis. Understanding what each method does well makes it easier to decide which numbers are worth tracking.
| Method | Strengths | Considerations | Best for |
|---|---|---|---|
| BMI | Universally used, requires only a scale, decades of population data behind it | Blind to fat distribution and to muscle mass. Misses central adiposity in women whose weight has stayed stable | Population-level tracking and clinical thresholds |
| Waist circumference alone | Directly reflects abdominal fat, simple to repeat | Not adjusted for height, so the same waist means different things on a 5 foot 1 frame and a 5 foot 10 frame | Tracking change in yourself over time |
| Waist-to-height ratio | Height-adjusted, works across sexes and ethnicities, no calculator needed | Coarser bands than BRI, less sensitive at the extremes | A fast first screen at home |
| Body roundness index | Height-adjusted estimate of visceral fat, ranked top predictor of metabolic syndrome in peri and postmenopausal women | Requires a calculator, thresholds still being validated across populations, sensitive to measurement error | Risk screening when BMI looks unremarkable |
| DEXA or CT imaging | Measures visceral fat directly rather than estimating it | Cost, access, and radiation exposure in the case of CT. Rarely ordered for screening | Clinical investigation when a precise answer is needed |
The practical approach is to layer them. Take waist-to-height as your quick monthly check, run BRI through a calculator once a quarter, and treat BMI as background context rather than the headline. If your BMI sits in the normal range while your waist-to-height ratio is above 0.5, that combination is the exact blind spot the body roundness index was built to catch.
Numbers describe risk. They do not diagnose anything. Metabolic syndrome is confirmed through blood work, blood pressure, and waist measurement together, and a raised BRI is a reason to ask for those tests rather than a substitute for them.
Know when to seek professional evaluation:
- Your waist-to-height ratio is 0.5 or above, or your BRI reads 6.9 or higher
- Your waist has grown by more than two inches in a year without a change in weight
- You have a family history of type 2 diabetes, heart disease, or stroke
- You have not had fasting glucose, HbA1c, or a lipid panel checked in the past two years
- You notice increased thirst, unexplained fatigue, or blurred vision
- Your BRI reads below 3.4, which is associated with elevated risk at the other end of the curve and warrants a conversation about nutrition and muscle mass
Where Botavive Berberine 1200 fits into a metabolic plan
Knowing your number is the starting point. The harder question is what moves it. Visceral fat responds to the same levers that improve insulin sensitivity, which is why resistance training, protein intake, and sleep quality show up in every credible recommendation. Nutritional support sits alongside those levers rather than in place of them.
Botavive Berberine 1200 delivers berberine HCl, a plant compound studied specifically for the metabolic markers this article covers. A 2025 systematic review and meta-analysis of randomized placebo-controlled trials in Frontiers in Pharmacology examined berberine across the components of metabolic syndrome. Waist circumference fell by a weighted mean of 3.27 centimeters compared with placebo. Triglycerides, fasting plasma glucose, LDL cholesterol, total cholesterol, and BMI all moved favorably. The reviewers reported no meaningful safety difference between berberine and placebo. Waist circumference is the input that drives your body roundness index, which makes it the most directly relevant of those findings here.
Berberine supports healthy glucose metabolism and healthy body composition as one component of a broader approach. It works best alongside the structural changes that address muscle mass and sleep, not as a replacement for them, and it is not a treatment for metabolic syndrome or any other condition. If you take medication for blood sugar or blood pressure, speak with your clinician before adding it.
Frequently asked questions
What is a good body roundness index for a woman over 50?
The large NHANES cohort study found the lowest all-cause mortality risk in the middle range of 4.5 to 5.5. Risk climbed 25% below 3.4 and 49% at 6.9 or above. Those thresholds come from a general adult population rather than a menopause-specific one, so treat them as orientation rather than a target to chase. The trend in your own number over time tells you more than any single reading.
Why is a low BRI also associated with higher risk?
The relationship is U-shaped, not linear. Readings at the low end often reflect low muscle mass, frailty, or underlying illness rather than good metabolic health. For women past 50 this matters, because sarcopenia becomes more common with age and a shrinking waist accompanied by shrinking strength is not a favorable sign.
My BMI is normal. Do I still need to check this?
Yes, and this is the group the measurement helps most. A normal BMI paired with a waist-to-height ratio above 0.5 describes central adiposity that BMI has missed entirely. Women whose weight held steady through perimenopause while their shape changed fall into this pattern regularly.
How often should I remeasure?
Monthly for waist-to-height, quarterly for the full body roundness index. Visceral fat responds to sustained change over months rather than weeks, and measuring more often mostly captures normal fluctuation in bloating and hydration.
Does hormone therapy change where fat is stored?
Research on menopausal hormone therapy and body composition suggests it influences fat distribution, and the Climacteric meta-analysis found different estrogen preparations affected metabolic syndrome components differently. This is a decision to work through with a clinician who knows your history, since the reasons for and against hormone therapy extend well beyond body composition.
Sources
- Xi Y, Sun Q, Han Y, et al., 2026. A body roundness index (BRI)-based predictive model for metabolic syndrome in perimenopausal and postmenopausal women. Annals of Medicine, 58(1):2682583. PubMed 42250232
- Zhang X, Ma N, Lin Q, et al., 2024. Body Roundness Index and All-Cause Mortality Among US Adults. JAMA Network Open, 7(6):e2415051. PubMed 38837158
- National Institute for Health and Care Excellence, 2025. Identifying and assessing overweight, obesity and central adiposity. NICE guideline NG246. NICE NG246
- Pu D, Tan R, Yu Q, Wu J, 2017. Metabolic syndrome in menopause and associated factors: a meta-analysis. Climacteric, 20(6):583-591. PubMed 29064321
- Liu D, Zhao H, Zhang Y, Hu J, Xu H, 2025. Efficacy and safety of berberine on the components of metabolic syndrome: a systematic review and meta-analysis of randomized placebo-controlled trials. Frontiers in Pharmacology, 16:1572197. PubMed 40740996